Innovation
26 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 780 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 17 |
| 2026 | 9 |
Social engagement
Social engagement: 22.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Morningside, Forbion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 62% |
| Private equity | 3 | 23% |
| Other / undisclosed | 2 | 15% |
Recent activity
16 Jun 2026
Leadership hire
Chief Commercial Officer
10 Jun 2026
Event
NLASessions 2026
8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference